MIRA INFORM REPORT

 

 

Report No. :

342316

Report Date :

26.09.2015

 

IDENTIFICATION DETAILS

 

Name :

IMIX ADR LIMITED

 

 

Registered Office :

Suites 3313-17, Jardine House, 1 Connaught Place, Central

 

 

Country :

Hongkong

 

 

Date of Incorporation :

14.06.2002

 

 

Com. Reg. No.:

32772257

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

Trading of medical radiographic system equipment.

 

 

No. of Employees :

Not Available

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ca

 

RATING

STATUS

PROPOSED CREDIT LINE

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

Limited with full security

 

 

Status :

Moderate

 

 

Payment Behaviour :

Unknown

 

 

Litigation :

Clear

 

 

NOTES:

Any query related to this report can be made on e-mail: infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – March 31, 2015

 

Country Name

Previous Rating

(31.12.2014)

Current Rating

(31.03.2015)

Hongkong

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

HONGKONG - ECONOMIC OVERVIEW

 

Hong Kong has a free market economy, highly dependent on international trade and finance - the value of goods and services trade, including the sizable share of re-exports, is about four times GDP. Hong Kong has no tariffs on imported goods, and it levies excise duties on only four commodities, whether imported or produced locally: hard alcohol, tobacco, hydrocarbon oil, and methyl alcohol. There are no quotas or dumping laws. Hong Kong's open economy left it exposed to the global economic slowdown that began in 2008. Although increasing integration with China, through trade, tourism, and financial links, helped it to make an initial recovery more quickly than many observers anticipated, its continued reliance on foreign trade and investment leaves it vulnerable to renewed global financial market volatility or a slowdown in the global economy. The Hong Kong government is promoting the Special Administrative Region (SAR) as the site for Chinese renminbi (RMB) internationalization. Hong Kong residents are allowed to establish RMB-denominated savings accounts; RMB-denominated corporate and Chinese government bonds have been issued in Hong Kong; and RMB trade settlement is allowed. The territory far exceeded the RMB conversion quota set by Beijing for trade settlements in 2010 due to the growth of earnings from exports to the mainland. RMB deposits grew to roughly 12.5% of total system deposits in Hong Kong by the end of 2014. The government is pursuing efforts to introduce additional use of RMB in Hong Kong financial markets and is seeking to expand the RMB quota. The mainland has long been Hong Kong's largest trading partner, accounting for about half of Hong Kong's total trade by value. Hong Kong's natural resources are limited, and food and raw materials must be imported. As a result of China's easing of travel restrictions, the number of mainland tourists to the territory has surged from 4.5 million in 2001 to 47.3 million in 2014, outnumbering visitors from all other countries combined. Hong Kong has also established itself as the premier stock market for Chinese firms seeking to list abroad. In 2014 mainland Chinese companies constituted about 50% of the firms listed on the Hong Kong Stock Exchange and accounted for about 60.1% of the Exchange's market capitalization. During the past decade, as Hong Kong's manufacturing industry moved to the mainland, its service industry has grown rapidly. Credit expansion and tight housing supply conditions have caused Hong Kong property prices to rise rapidly; consumer prices increased by more than 4.4% in 2014. Lower and middle income segments of the population are increasingly unable to afford adequate housing. Hong Kong continues to link its currency closely to the US dollar, maintaining an arrangement established in 1983. In 2014, Hong Kong and China signed a new agreement on achieving basic liberalization of trade in services in Guangdong Province under the Closer Economic Partnership Agreement, adopted in 2003 to forge closer ties between Hong Kong and the mainland. The new measures, effective from March 2015, cover a negative list and a most-favored treatment provision, and will improve access to the mainland's service sector for Hong Kong-based companies.

 

Source : CIA


Contact Points

 

Company Name (in English):

Imix Adr Limited

Supplied Name:

IMIX ADR LTD

Supplied Address:

JARDINE HOUSE, SUITE 3313-3317 I, CONNAUGHT PLACE CENTRE CENTRAL HONG KONG

Note: The exact name is as above.

 

 

Company Identification Details

 

Registered Name:

Imix Adr Limited

Registered Address:

Suites 3313-17, Jardine House, 1 Connaught Place, Central, Hong Kong

Telephone Number:

+852-6271-5886

Date of Registration:

2002-06-14

Registered Number:

802071

Business Registration No.:

32772257

Paid-up Capital:

HKD 78,759,528.93 (USD 10,159,979.23) = 29,997 Shares @ HKD 2625.6

(As of 2015.09, 1 HKD = 0.129 USD)

Legal Form:

Private Limited Liability Company

SITC Code:

77421-- Apparatus based on the use of x-rays (No.)

Principal Activities:

Trading of medical radiographic system equipment, etc.

Staff:

N/A

Listed at Stock Exchange:

No

Date of Last Annual Return:

2015-06-14

 

Notes: Subject declined to disclose the number of staff, and we cannot obtain the information from other source, either. The supplied Number +852-2868-4339 is not available.

 

 

History

 

Subject was incorporated on 2002-06-14 with the registered number 802071 as Private Limited Liability Company in Hong Kong.

 

Transfer of Shares:

 

2014-07-31

Transferred From

No. of Shares Transferred

Transferred To

IMIX Holding AB

29,997

Arcoma Aktiebolag

 

 

Corporate Structure

 

Related Companies

Name:

Arcoma North America, Inc.

Address:

23112 Alcalde Drive, Suite A Laguna Hills, California 92653

USA

Phone:

+1-704-897-0305

E-mail:

americas@imixadr.com

 

Group Offices

1

Region:

Europe, Middle-East and Africa

Name:

Arcoma AB

Address:

Annavagen 1, S-352 46 Vaxjo, Sweden

Phone:

+46-4-7070-6970/6900

E-mail:

service@arcoma.se office@arcoma.se

2

Region:

Americas

Phone:

+1-704-897-0305

E-mail:

service@imixadr.com

3

Region:

Asia-Pacific 

Phone:

+86-135-0108-9559

E-mail:

support-asia@imixadr.com

 

 

Shareholder

 

Name

Subscription Shares 

Proportion of Investment (%)

Arcoma Aktiebolag

29,997

100%

Total

29,997

100%

 

 

Major Shareholder Information:

1

Name:

Arcoma Aktiebolag

Address:

Annavagen 1, S-352 46 Vaxjo, Sweden

 

Former Shareholder Information:

Name:

IMIX Holding AB

Address:

Annavagen 1, S-352 46 Vaxjo, Sweden

 

 

Management Information

 

Core Management

 

Detailed Information of Directors:

1

Name:

Reinli Peter Willi Fredrik

Address:

Flat 26B, No.2 Park Road, Mid Levels West, Hong Kong

Position:

Director

ID Number:

P822952 (3)

2

Name:

Mannheimer Swartling Hong Kong Limited

Address:

Suites 3313-17, Jardine House, 1 Connaught Place, Central, Hong Kong

Position:

Corporate Secretary

Registered Number:

1073669

 

 

Operation Information

 

Offices & Factories

We cannot confirm subject current trading address at this stage.

 

Production Information

Subject is a trader of medical radiographic system equipment, etc. 

 

Purchase Information

It is introduced that the products of subject are mostly purchased from abroad.

 

Sales Information

Subject is engaged in sales of medical radiographic system equipment, etc.

The major products are complete radiographic system, radiographic system components and mobile imaging tables, etc.

Subject’s sales regions include domestic market, Southeast Asia, North America and Europe, etc.

It is introduced that subject has sales offices in Mainland China and USA.

Subject’s major customers are hospitals, clinics, imaging centers and private practices, etc.

 

 

Settlements

 

Purchase

Domestic Purchase

 

Subject has little domestic purchase.

 

Import

Products

Medical radiographic system equipment, etc.

Payment Terms

L/C, T/T, etc.

 

Sales

 

Domestic Markets

Product

Medical radiographic system equipment, etc.

Selling Terms

T/T, Cash, etc.

 

Export

Product

Medical radiographic system equipment, etc.

Selling Terms

L/C, T/T, etc.

 

 

Financial Information

 

The subject has no obligation to supply its financial statement to the third party according to the relevant policy in Hong Kong and the only source from which we can obtain the information is the subject itself.

 

Subject’s relevant staff rejected to disclose the financial information, and from other sources we could not obtain such information, either.

 

 

Bankers

 

Subject declined to disclose its bank details; from other source we could not obtain the relevant information, either.

 

 

Public

 

Civil Litigation

Up to now, no present or latent civil litigation of the subject has been found.

 

Mortgage Record

 

Company Name:

Imix Adr Limited

Instrument of Creating Mortgage:

Debenture

Date of Creating Mortgage:

2007-07-17

Amount Secured:

By clause 2 of the Debenture, the Secured Obligations

Name of Mortgagee:

Svenska Handelsbanken AB (publ), Shanghai Branch (the “Bank”)

Address of Mortgagee:

Room 408-410, Bund No.12 Building, Zhongshan Dong Yi Road, Shanghai 20002 China

Description of Property Mortgaged:

By clause 3 of the Debenture, as a continuing security for the discharge on demand of the Secured Obligations and as beneficial owner, the Company:

(1)        charges to the Bank:-

(a)        by way of first fixed charge:-

(i)         all the plant, machinery, fixtures and fittings on or after 17,h July 2007 belonging to the Company and all right, title and interest of the Company under any agreements (present or future) relating to the purchase, lease or hire purchase of the same;

 

(ii)         all vehicles, computers, furniture, equipment, tools and other chattels belonging to the Company on or after 17th July 2007 not regularly disposed of in the ordinary course of business and all right, title and interest of the Company under any agreements (present or future) relating to the purchase, lease or hire purchase of the same;

(iii)        all the goodwill and uncalled capital of the Company present and future;

(iv)        all intellectual property rights belonging to the Company on or after 17th July 2007;

(v)        all shares, stock, debentures and other securities (whether, without limitation, certificated or uncertificated or units of security in an account or balance (whether held as a member or by a nominee) within any clearing, settlement or transfer system whatsoever and wherever situated) belonging to the Company on or after 17th July 2007 together with all the right, title and interest in and to dividends, interest and other income and all voting and all other rights of whatsoever kind;

(vi)        all book debts and other debts owing to the Company on or after 17th July 2007 and the proceeds of payment or realisation of each of them until the payment of such proceeds into the Proceeds Account;

(vii)       all negotiable instruments at any time drawn, issued or endorsed in favour of, or held by or on behalf of, the Company, including any such instruments which at any time have been deposited with the Bank (whether or not endorsed to the Bank);

(viii)      all funds standing to the credit of the Company from time to time on any account with any bank or financial institution, including the Proceeds Account;

(ix)        all choses in action and claims belonging to the Company on or after 17th July 2007; and

 

(b)        by way of first fixed equitable charge all estates or interests in any real property vested in or charged to the Company on or after 17th July 2007; and

 

(c)        by way of floating charge all the undertaking and all property, assets and rights of the Company present and future wherever situate not from time to time subject to a mortgage, fixed charge or assignment under the Debenture; and

 

(2)        assigns to the Bank:-

(a)        the proceeds of each policy of insurance issued on or after 17th July 2007 in relation to the Company's real property and the other assets charged by the Debenture, subject to reassignment on redemption;

(b)the benefit of all covenants and rights relating to the Company*s real property and the benefit of all easements serving or relating to such property, subject to reassignment on redemption; and

(c)        the benefit of any interest rate swap, currency swap, cap or collar arrangement, future, option, forward rate agreement or other derivative instrument (howsoever described) or any other agreement with the Bank or any third party for protecting or hedging any of the Secured Obligations at any time, subject to reassignment on redemption.

((1) and (2) collectively the "Charged Property")

 

 

Lawsuits

 

Up to now, no present or latent litigation of the subject has been found.

 

 

Special Note

 

Interview Details

Name

The Operator

 

 

Industry Information

 

77421-- Apparatus based on the use of X-rays (No.)

Unit: HKD/000

 

2015.6

2015.01~2015.6

 

Quantity

Value

Quantity

Value

Imports

France

230

21,697

659

49,097

Singapore

6

511

9

4,056

Malaysia

1

3,459

7

8,120

Germany

1

1,157

81

27,559

America

45

21,830

368

149,683

Vietnam

2

140

10

1,068

Japan

10

2,906

70

13,667

Korea

1

1,638

29

11,749

Taiwan

50

1,285

151

3,871

The Mainland of China

13

5,657

80

28,640

Exports

Thailand 

1

178

1

178

Singapore

2

1,600

2

1,600

Russia

1

54

1

54

Germany

1

170

8

4,343

Vietnam

6

1,508

14

2,239

Japan

--

--

1

2,786

Korea

--

--

4

2,365

Taiwan

3

1,225

3

1,225

The Mainland of China

106

83,339

636

352,372

 

 

External Trade Information:

 

External Merchandise Trade Aggregate Figures

Unit: HKD/ Million

 

Imports

Domestic Exports

Re-exports

Total exports

Year-on-year % change of Total exports

Merchandise trade balance

2012

3,912,163

58,830

3,375,516

3,434,346

+2.9

-477,817

2013

4,060,717

54,364

3,505,322

3,559,686

+3.6

-501,031

2014

4,219,046

55,283

3,617,468

3,672,751

+3.2

-546,295

2014.05

348,323

5,299

300,673

305,973

+4.9

-42,350

2014.06

352,316

4,802

304,409

309,211

+11.4

-43,105

2014.07

368,293

5,120

321,040

326,160

+6.8

-42,132

2014.08

358,750

5,289

321,937

327,225

+6.4

-31,525

2014.09

382,355

4,153

327,833

331,986

+4.5

-50,369

2014.10

381,569

4,392

327,335

331,727

+2.7

-49,842

2014.11

378,946

4,701

322,082

326,783

+0.4

-52,163

2014.12

372,007

4,050

308,705

312,755

+0.6

-59,253

2015.01

348,886

4,468

307,403

311,871

+2.8

-37,015

2015.02

264,220

2,919

225,418

228,337

+7.2

-35,884

2015.03

342,319

4,013

292,100

296,113

-1.8

-46,206

2015.04

331,108

4,202

287,742

291,944

+2.2

-39,164

2015.05

331,940

4,258

287,571

291,830

-4.6

-40,110

2015.06

345,302

4,158

295,361

299,518

-3.1

-45,783

 

*Total exports figures have been rounded to the nearest final digit after summing up the constituent trade figures.

 

 


Attachment

 

We arranged the site visit to the supplied address, and we found another company named Mannheimer Swartling Advokatbyra AB, which is engaged in providing the services of registration and consulting, etc. The relevant staff of the company introduced that subject registered on his address. But he declined to disclose any other information.

 

Address: Suite 3313-3317 I, Jardine House, Connaught Place Centre Central, Hong Kong

 

Jardine House, Connaught Place Centre Central, Hong Kong

IMG_1
 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 


33/F, Jardine House, Connaught Place Centre Central, Hong Kong

 

IMG_3
 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 


Suite 3313-3317 I, Jardine House, Connaught Place Centre Central, Hong Kong

IMG_4
 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 


 


FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.66.10

UK Pound

1

Rs.100.89

Euro

1

Rs.73.96

 

INFORMATION DETAILS

 

Analysis Done by :

KIN

 

 

Report Prepared by :

NIT

 

               

RATING EXPLANATIONS

 

RATING

STATUS

PROPOSED CREDIT LINE

 

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

 

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

 

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

 

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

 

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

 

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

 

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

Credit not recommended

 

--

NB

New Business

--

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.